Recovery

Health care in the United States is not a free market. In many ways, U.S. residents are less free to make their own health decisions than residents of other nations. Government controls a larger share of health spending in the United States than in Canada, the United Kingdom, and most other advanced nations. State and federal governments subsidize low-quality medical care and penalize high-quality care. They block innovations that would otherwise reduce medical prices. Congress even funds veterans benefits in a way that increases the likelihood of war.

Fortunately, there are corners of the U.S. health sector where market forces have had room to breathe. In those areas, markets have made health care better, more affordable, and more secure. They have made health care more universal—both in the United States and in nations that supposedly already had universal health care. Sometimes, market forces develop such innovations despite government policies that exist explicitly to block them.

Those sorts of innovations should be exploding across the United States and the world, bringing affordable health care to low-income patients and driving high-cost and low-quality providers and insurers out of business. But they aren’t.

Recovery shows that making health care as universal as possible requires ending all barriers that government places in the way of better, more affordable, and more secure health care.

Michael F. Cannon is the Cato Institute’s director of health policy studies. Cannon is “an influential health‐​care wonk” (Washington Post), “ObamaCare’s single most relentless antagonist” (New Republic), “ObamaCare’s fiercest critic” (The Week), “the intellectual father” of King v. Burwell (Modern Healthcare), and “the most famous libertarian health care scholar” (Washington Examiner). Washingtonian magazine named Cannon one of Washington, DC’s “Most Influential People” in 2021, 2022, 2023, 2024.